P L Anderson
Overview
    Explore the profile of P L Anderson including associated specialties, affiliations and a list of published articles.
          
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              42
            
            
              Citations
              345
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          Published In
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Hampanda K, Grubbs H, Castillo-Mancilla J, Anderson P, Thorne J, Helova A, et al.
  
  
    AIDS Care
    . 2024 Aug;
          36(12):1826-1837.
    
    PMID: 39106970
  
  
          Adherence to antiretroviral therapy (ART) remains sub-optimal among pregnant and postpartum women with HIV (PPWH) in high HIV prevalence low resource settings with few effective behavioral interventions. A large body...
      
2.
        
    
    Singh Y, Castillo-Mancilla J, Madimabe R, Jennings L, Ferraris C, Robbins R, et al.
  
  
    AIDS Res Ther
    . 2023 Sep;
          20(1):67.
    
    PMID: 37705102
  
  
          Background: Suboptimal antiretroviral (ART) adherence can lead to virologic failure with consequent HIV-1 resistance. Tenofovir diphosphate (TFV-DP) in dried blood spots (DBS) is a powerful biomarker of cumulative adherence, predictive...
      
3.
        
    
    Robbins R, Kluisza L, Nguyen N, Dolezal C, Leu C, Wiznia A, et al.
  
  
    AIDS Behav
    . 2023 Jun;
          27(12):3927-3931.
    
    PMID: 37326692
  
  
          Tenofovir diphosphate (TVF-DP) can be quantified in red blood cells (RBCs) and dried blood spots (DBS) and can objectively measure ART adherence and predict viral suppression. Data on the association...
      
4.
        
    
    Maahs D, Bushman L, Kerr B, Ellis S, Pyle L, McFann K, et al.
  
  
    J Diabetes Complications
    . 2014 Jul;
          28(5):667-73.
    
    PMID: 25027389
  
  
          Aims: Improved early diagnostic methods are needed to identify risk for kidney disease in people with type 1 diabetes. We hypothesized that glomerular filtration rate (GFR) measured by iohexol clearance...
      
5.
        
    
    Kiser J, Carten M, Aquilante C, Anderson P, Wolfe P, King T, et al.
  
  
    Clin Pharmacol Ther
    . 2007 Jun;
          83(2):265-72.
    
    PMID: 17597712
  
  
          We determined the effects of lopinavir/ritonavir on tenofovir renal clearance. Human immunodeficiency virus-infected subjects taking tenofovir disoproxil fumarate (TDF) were matched on age, race, and gender and were enrolled into...
      
6.
        
    
    Anderson P, Meier-Hedde R
  
  
    J Learn Disabil
    . 2004 Oct;
          34(1):9-21.
    
    PMID: 15497269
  
  
          Current understanding of reading disabilities is rooted in the early observations of physicians dating as far back in history as the 17th century. This article reviews medical case study research...
      
7.
        
    
    Anderson P, Rothbaum B, Hodges L
  
  
    Bull Menninger Clin
    . 2001 Apr;
          65(1):78-91.
    
    PMID: 11280960
  
  
          Mental health professionals are increasingly integrating advances in technology to improve the health of those in their care (American Psychological Association, 2000). The authors describe the immersive properties of virtual...
      
8.
        
    
    Kakuda T, Page L, Anderson P, Henry K, Schacker T, Rhame F, et al.
  
  
    Antimicrob Agents Chemother
    . 2000 Dec;
          45(1):236-42.
    
    PMID: 11120972
  
  
          Conventional antiretroviral therapy involves administration of standard fixed doses to adults and adolescents. This approach ignores interindividual variability in pharmacokinetics and results in substantial differences in systemic concentrations among patients....
      
9.
        
    
    Anderson P, Brundage R, Bushman L, Kakuda T, Remmel R, Fletcher C
  
  
    AIDS
    . 2000 Nov;
          14(15):2293-7.
    
    PMID: 11089617
  
  
          Objective: To quantify unbound indinavir concentrations and characterize indinavir plasma protein binding in HIV-infected adults. Design: Pharmacokinetic study in antiretroviral-naive, HIV-infected persons with CD4 T lymphocytes > 100 x 10(6)...
      
10.
        
    
    Fletcher C, Kawle S, Kakuda T, Anderson P, Weller D, Bushman L, et al.
  
  
    AIDS
    . 2000 Nov;
          14(14):2137-44.
    
    PMID: 11061655
  
  
          Objective: To quantitate intracellular concentrations of zidovudine and lamivudine triphosphate and explore relationships with virologic and immunologic responses to antiretroviral therapy. Design: Eight antiretroviral-naive, HIV-infected persons with CD4 T cell...